• Patients
  • Careers
  • Contact
Frequency Therapeutics
  • About

    About

    We are a clinical-stage biotechnology company focused on restoring function by developing therapeutics that activate a person’s innate regenerative potential.

    • About Us
    • Leadership
    • Board of Directors
    • PCA Regenerative Medicine Advisory Board
    • Hearing Clinical Advisory Board
    • Remyelination Advisory Board
  • Our Science

    Our Science

    Frequency is leading a new category in regenerative medicine designed to activate a person’s innate regenerative potential, within the body, to repair tissue and restore function.

    • PCA Approach
    • Therapeutic Discovery Process
    • Publications
  • Pipeline & Programs

    Pipeline & Programs

    Developing small-molecule treatments to reverse the debilitating impact of degenerative diseases

    • Pipeline
    • Hearing Program
    • Multiple Sclerosis Program
    • Strategic Partnerships
  • Hearing Loss

    Hearing Loss

    Hearing loss caused by damage to the sensory cells of the ear impacts hundreds of millions of people globally. Currently there are no FDA-approved treatments to address the underlying condition.

    • About Hearing Loss
    • How We Hear
    • Sensorineural Hearing Loss
    • Sound Clarity and Speech Perception
    • Hearing Loss: A Growing Public Health Problem
  • Investors & Media

    Investors & Media

    • Overview
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • Investor FAQ
    • Investor & Media Contacts
  • About
    • About Us
    • Leadership
    • Board of Directors
    • PCA Regenerative Medicine Advisory Board
    • Hearing Clinical Advisory Board
    • Remyelination Advisory Board
  • Our Science
    • PCA Approach
    • Therapeutic Discovery Process
    • Publications
  • Pipeline & Programs
    • Pipeline
    • Hearing Program
    • Multiple Sclerosis Program
    • Strategic Partnerships
  • Hearing Loss
    • About Hearing Loss
    • How We Hear
    • Sensorineural Hearing Loss
    • Sound Clarity and Speech Perception
    • Hearing Loss: A Growing Public Health Problem
  • Investors & Media
    • Overview
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • Investor FAQ
    • Investor & Media Contacts
  • Patients
  • Careers
  • Contact Us

PCA Regenerative Medicine Advisory Board

Read Bio

James Rothman, Ph.D.

Sterling Professor of Cell Biology at Yale University, Chairman of the Yale School of Medicine’s Department of Cell Biology and the Director and founder of the Nanobiology Institute

Read Bio

Robert S. Langer, ScD

Institute Professor, Massachusetts Institute of Technology

Read Bio

Jeff Karp, PhD

Harvard Medical School; Brigham & Women's Hospital

Read Bio

Steve Haggarty, PhD

Harvard Medical School; Broad Institute of MIT & Harvard

Read Bio

Ralph Mazitschek, PhD

Harvard Medical School; Center for Systems Biology at MGH.

Read Bio

Peter Schultz, PhD

Scripps Research Center

Read Bio

Jeffrey Holt, PhD

Harvard Medical School; Boston Children’s Hospital

Read Bio

Ken Anderson, MD

Dana-Farber Cancer Institute

Read Bio

Xiaolei Yin, PhD

Harvard Medical School; Brigham & Women’s Hospital

Read Bio

John LaMattina, PhD

PureTech Health; Former President of R&D, Pfizer

Read Bio

Sean J. Morrison, PhD

UT Southwestern; Howard Hughes Medical Institute

Read Bio

Siddhartha Mukherjee, MD, DPhil

Columbia University

Read Bio

Amy Wagers, PhD

Harvard University; Joslin Diabetes Center

Read Bio

Sheng Ding, PhD

Gladstone Institute of Cardiovascular Disease; University of California San Francisco

Interested in joining our team? Explore careers

© 2023 Frequency Therapeutics
  • Open Positions
  • Contact
  • Privacy Policy
  • Terms & Conditions